{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:04:19Z","timestamp":1770764659308,"version":"3.50.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hyperinflammation and extensive cell damage characterize both COVID-19-sepsis and bacterial sepsis, contributing to poor clinical outcomes. Cell-free DNA (cfDNA), a damage-associated molecular pattern (DAMP), reflects ongoing tissue injury and may predict mortality. We aimed to evaluate cfDNA as a prognostic biomarker for 30-day mortality in ICU patients with COVID-19- vs. bacterial sepsis, and its association with inflammatory markers and disease progression. In a prospective observational study (ethics approval: 2020\u201315,535; DRKS-ID: DRKS00025222), cfDNA was quantified in 64 ICU patients (COVID-19-sepsis n\u2009=\u200927, bacterial sepsis n\u2009=\u200937) at four time points using quantitative PCR targeting 90\u00a0bp and 222\u00a0bp fragments of LINE-1 elements. An Integrity Index (222\/90\u00a0bp) was calculated to infer the predominant mode of cell death. Nineteen healthy individuals served as controls. Associations with mortality and clinical parameters were analyzed using adjusted Cox regression, time-dependent models, and correlation analyses. Higher cfDNA levels (90\u00a0bp) within the first 24\u00a0h were strongly associated with 30-day (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003) and 180-day mortality (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003) in COVID-19-sepsis, but not in bacterial sepsis. COVID-19 patients showed significantly higher cfDNA levels (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), which correlated with CRP, PCT, LDH, and lactate. The Integrity Index increased over time in bacterial sepsis and remained stable in COVID-19-sepsis, but was not predictive of survival. Elevated cfDNA levels were associated with ECMO therapy but not with renal replacement therapy. cfDNA is a valuable early prognostic biomarker in COVID-19-sepsis. Its rapid dynamics and strong correlation with clinical outcomes highlight its potential for real-time monitoring and risk stratification in viral sepsis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-32810-4","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:25:52Z","timestamp":1766071552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospective observational study of cell-free DNA as a prognostic biomarker in COVID-19 and bacterial sepsis: COVSEP-study"],"prefix":"10.1038","volume":"15","author":[{"given":"Katharina","family":"Hoeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmo W. I.","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Jochum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kuchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira","family":"Enders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K. E.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perikles","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bodenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"17","key":"32810_CR1","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.3390\/ijms22179110","volume":"22","author":"FS de Miranda","year":"2021","unstructured":"de Miranda, F. S. et al. Properties and application of cell-free DNA as a clinical biomarker. Int. J. Mol. Sci. 22(17), 9110 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"32810_CR2","doi-asserted-by":"publisher","first-page":"175346662093717","DOI":"10.1177\/1753466620937175","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang, I. et al. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther. Adv. Respir. Dis. 14, 1753466620937175 (2020).","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"5","key":"32810_CR3","doi-asserted-by":"publisher","first-page":"offa153","DOI":"10.1093\/ofid\/ofaa153","volume":"7","author":"G Wang","year":"2020","unstructured":"Wang, G. et al. C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect. Dis. 7(5), offa153 (2020).","journal-title":"Open Forum Infect. Dis."},{"issue":"10","key":"32810_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26(10), 1636\u20131643 (2020).","journal-title":"Nat. Med."},{"issue":"1","key":"32810_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","volume":"146","author":"T Herold","year":"2020","unstructured":"Herold, T. et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J. Allergy Clin. Immunol. 146(1), 128-136.e4 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7816","key":"32810_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 583(7816), 437\u2013440 (2020).","journal-title":"Nature"},{"issue":"11","key":"32810_CR7","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll, T., Shankar-Hari, M. & Wiersinga, W. J. The immunology of sepsis. Immunity 54(11), 2450\u20132464 (2021).","journal-title":"Immunity"},{"key":"32810_CR8","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3389\/fimmu.2019.02536","volume":"10","author":"NL Denning","year":"2019","unstructured":"Denning, N. L. et al. DAMPs and NETs in Sepsis. Front Immunol 10, 2536 (2019).","journal-title":"Front Immunol"},{"key":"32810_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.708302","volume":"12","author":"C Gillot","year":"2021","unstructured":"Gillot, C. et al. NETosis and the immune system in COVID-19: mechanisms and potential treatments. Front. Pharmacol. 12, 708302 (2021).","journal-title":"Front. Pharmacol."},{"key":"32810_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fimmu.2016.00311","volume":"7","author":"BN Porto","year":"2016","unstructured":"Porto, B. N. & Stein, R. T. Neutrophil extracellular traps in pulmonary diseases: too much of a good thing?. Front. Immunol. 7, 311 (2016).","journal-title":"Front. Immunol."},{"issue":"6","key":"32810_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20(6), 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"32810_CR12","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16072","volume":"11","author":"K Hoeter","year":"2023","unstructured":"Hoeter, K. et al. Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: A retrospective pilot study. PeerJ 11, e16072 (2023).","journal-title":"PeerJ"},{"issue":"1","key":"32810_CR13","doi-asserted-by":"publisher","first-page":"19624","DOI":"10.1038\/s41598-023-46663-2","volume":"13","author":"A Charoensappakit","year":"2023","unstructured":"Charoensappakit, A. et al. Cell-free DNA as diagnostic and prognostic biomarkers for adult sepsis: A systematic review and meta-analysis. Sci. Rep. 13(1), 19624 (2023).","journal-title":"Sci. Rep."},{"issue":"4","key":"32810_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.medj.2021.01.001","volume":"2","author":"AP Cheng","year":"2021","unstructured":"Cheng, A. P. et al. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity. Med 2(4), 411-422.e5 (2021).","journal-title":"Med"},{"issue":"7","key":"32810_CR15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/ijms18071350","volume":"18","author":"F Salvianti","year":"2017","unstructured":"Salvianti, F. et al. Integrity and quantity of total cell-free DNA in the diagnosis of thyroid cancer: Correlation with cytological classification. Int. J. Mol. Sci. 18(7), 1350 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"32810_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8), 801\u2013810 (2016).","journal-title":"JAMA"},{"issue":"1","key":"32810_CR17","doi-asserted-by":"publisher","first-page":"13581","DOI":"10.1038\/s41598-021-92826-4","volume":"11","author":"EWI Neuberger","year":"2021","unstructured":"Neuberger, E. W. I. et al. Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients. Sci Rep 11(1), 13581 (2021).","journal-title":"Sci Rep"},{"key":"32810_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00439-002-0904-2","volume":"112","author":"A Buzdin","year":"2003","unstructured":"Buzdin, A. et al. Genome-wide targeted search for human specific and polymorphic L1 integrations. Hum. Genet. 112, 527\u2013533 (2003).","journal-title":"Hum. Genet."},{"issue":"2","key":"32810_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/v14020321","volume":"14","author":"R Stawski","year":"2022","unstructured":"Stawski, R., Nowak, D. & Perdas, E. Cell-free DNA: potential application in COVID-19 diagnostics and management. Viruses 14(2), 321 (2022).","journal-title":"Viruses"},{"key":"32810_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.963955","volume":"13","author":"CL Zhu","year":"2022","unstructured":"Zhu, C. L. et al. Dysregulation of neutrophil death in sepsis. Front Immunol 13, 963955 (2022).","journal-title":"Front Immunol"},{"issue":"8","key":"32810_CR21","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1111\/jch.14308","volume":"23","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Risk factors for the delayed viral clearance in COVID-19 patients. J Clin Hypertens (Greenwich) 23(8), 1483\u20131489 (2021).","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"32810_CR22","unstructured":"Stefan Kluge, U.J., Tobias Welte, Steffen Weber-Carstens, Gereon Sch\u00e4lte, Christoph D. Spinner, Jakob J. Malin, Petra Gastmeier, Florian Langer, Hendrik Bracht, Michael Westhoff, Michael Pfeifer, Klaus F. Rabe, Florian Hoffmann, Bernd W. B\u00f6ttiger, Julia Weinmann-Menke, Alexander Kersten, Peter Berlit, Marcin Krawczyk, Wiebke Nehls, Reiner Haase, Oliver J. M\u00fcller, Christof Specker, Monika Nothacker, Nicole Skoetz, Gernot Marx, Christian Karagiannidis. S3-Leitlinie - Empfehlungen zur Therapie von Patienten mit COVID-19. AWMF online 2023 [cited 2023 05.04.2023]; Available from: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/113-001LG."},{"issue":"1\u20133","key":"32810_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000440975","volume":"41","author":"A Clementi","year":"2016","unstructured":"Clementi, A. et al. The role of cell-free plasma DNA in critically Ill patients with sepsis. Blood Purif. 41(1\u20133), 34\u201340 (2016).","journal-title":"Blood Purif."},{"issue":"1","key":"32810_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcrc.2015.10.013","volume":"31","author":"YQ Hou","year":"2016","unstructured":"Hou, Y. Q. et al. Branched DNA-based Alu quantitative assay for cell-free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome. J. Crit. Care 31(1), 90\u201395 (2016).","journal-title":"J. Crit. Care"},{"issue":"8","key":"32810_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305895","volume":"19","author":"MN Dadam","year":"2024","unstructured":"Dadam, M. N. et al. Role of cell-free DNA levels in the diagnosis and prognosis of sepsis and bacteremia: A systematic review and meta-analysis. PLoS ONE 19(8), e0305895 (2024).","journal-title":"PLoS ONE"},{"issue":"6","key":"32810_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1373\/clinchem.2006.068577","volume":"52","author":"N Umetani","year":"2006","unstructured":"Umetani, N. et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin. Chem. 52(6), 1062\u20131069 (2006).","journal-title":"Clin. Chem."},{"key":"32810_CR27","doi-asserted-by":"publisher","first-page":"653228","DOI":"10.3389\/fcimb.2021.653228","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Review: The emerging role of neutrophil extracellular traps in sepsis and sepsis-associated thrombosis. Front. Cell. Infect. Microbiol. 11, 653228 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"32810_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100514","volume":"9","author":"A Avriel","year":"2014","unstructured":"Avriel, A. et al. Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care. PLoS ONE 9(6), e100514 (2014).","journal-title":"PLoS ONE"},{"issue":"17","key":"32810_CR29","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.3390\/jcm12175616","volume":"12","author":"A Clementi","year":"2023","unstructured":"Clementi, A. et al. Plasma cell-free DNA and caspase-3 levels in patients with chronic kidney disease. J. Clin. Med. 12(17), 5616 (2023).","journal-title":"J. Clin. Med."},{"issue":"2","key":"32810_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/jpm11020151","volume":"11","author":"P Mondelo-Mac\u00eda","year":"2021","unstructured":"Mondelo-Mac\u00eda, P. et al. Circulating free DNA and its emerging role in autoimmune diseases. J. Personal. Med. 11(2), 151 (2021).","journal-title":"J. Personal. Med."},{"issue":"11","key":"32810_CR31","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1111\/aor.14616","volume":"47","author":"MP Lingel","year":"2023","unstructured":"Lingel, M. P. et al. Clinical relevance of cell-free DNA during venovenous extracorporeal membrane oxygenation. Artif. Organs 47(11), 1720\u20131731 (2023).","journal-title":"Artif. Organs"},{"issue":"1","key":"32810_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1365-2249.1992.tb05831.x","volume":"90","author":"P Rumore","year":"1992","unstructured":"Rumore, P. et al. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin. Exp. Immunol. 90(1), 56\u201362 (1992).","journal-title":"Clin. Exp. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32810-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32810-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32810-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:58:52Z","timestamp":1766138332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32810-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["32810"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32810-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors of this study confirm that the study was conducted to investigate a new biomarker for its prognostic value regarding the outcome of ICU patients with COVID-19-sepsis and bacterial sepsis.The study was approved by the Ethics Committee (Landes\u00e4rztekammer Rheinland-Pfalz; 2020\u201315535) and informed consent was obtained from participants. All methods involving human participants were performed in accordance with the ethical standards of the Declaration of Helsinki. This is an independent review board to which the institution University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany is assigned.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work the author used Deep L Write in order to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}}],"article-number":"44144"}}